Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Incidence of Hyperfibrinolysis During Vaginal Delivery and Cesarean Section

NCT05975112 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT05975112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05975112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Incidence of Hyperfibrinolysis During Vaginal Delivery and Cesarean Section
Lead sponsor
Medical University of Graz
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2023
Completion date
April 17, 2025
Enrollment
780 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cesarean section complications, coagulation defect; bleeding, hyperfibrinolysis, peripartum haemorrhage